Mario Francisco P. Juruena
Mario Francisco P. Juruena
King's College London, Dept. Psycho Medicine, Inst. Psychiatry, Psychology and Neuroscience.
Bestätigte E-Mail-Adresse bei kcl.ac.uk - Startseite
Titel
Zitiert von
Zitiert von
Jahr
mhGAP intervention guide for mental, neurological and substance use disorders in non-specialized health settings: mental health Gap Action Programme (mhGAP)
World Health Organization
World Health Organization, 2010
7702010
The role of early life stress in adult psychiatric disorders: a systematic review according to childhood trauma subtypes
CP Carr, CMS Martins, AM Stingel, VB Lemgruber, MF Juruena
The Journal of nervous and mental disease 201 (12), 1007-1020, 2013
5542013
The hypothalamic pituitary adrenal axis, glucocorticoid receptor function and relevance to depression
MF Juruena, AJ Cleare, CM Pariante
Brazilian Journal of Psychiatry 26 (3), 189-201, 2004
282*2004
Guidelines of the Brazilian Medical Association for the treatment of depression (complete version)
MP Fleck, B Lafer, EB Sougey, JA Del Porto, MA Brasil, MF Juruena, ...
Revista brasileira de psiquiatria (Sao Paulo, Brazil: 1999) 25 (2), 114, 2003
227*2003
Review of the guidelines of the Brazilian Medical Association for the treatment of depression (Full version)
MP Fleck, MT Berlim, B Lafer, EB Sougey, JAD Porto, MA Brasil, ...
Brazilian Journal of Psychiatry 31, S7-S17, 2009
186*2009
Early-life stress and HPA axis trigger recurrent adulthood depression
MF Juruena
Epilepsy & Behavior 38, 148-159, 2014
1682014
Different responses to dexamethasone and prednisolone in the same depressed patients
MF Juruena, AJ Cleare, AS Papadopoulos, L Poon, S Lightman, ...
Psychopharmacology 189 (2), 225-235, 2006
1332006
The impact of childhood adversity on suicidality and clinical course in treatment-resistant depression
C Tunnard, LJ Rane, SC Wooderson, K Markopoulou, L Poon, A Fekadu, ...
Journal of affective disorders 152, 122-130, 2014
1262014
Lack of clinical therapeutic benefit of antidepressants is associated overall activation of the inflammatory system
LA Carvalho, JP Torre, AS Papadopoulos, L Poon, MF Juruena, ...
Journal of affective disorders 148 (1), 136-140, 2013
1222013
Effects of lithium on oxidative stress parameters in healthy subjects
R Khairova, R Pawar, G Salvadore, MF Juruena, RT De Sousa, ...
Molecular medicine reports 5 (3), 680-682, 2012
1192012
Prednisolone suppression test in depression: prospective study of the role of HPA axis dysfunction in treatment resistance
MF Juruena, CM Pariante, AS Papadopoulos, L Poon, S Lightman, ...
The British Journal of Psychiatry 194 (4), 342-349, 2009
1062009
The ratio of cortisol/DHEA in treatment resistant depression
K Markopoulou, A Papadopoulos, MF Juruena, L Poon, CM Pariante, ...
Psychoneuroendocrinology 34 (1), 19-26, 2009
982009
Atypical depression and non-atypical depression: is HPA axis function a biomarker? A systematic review
MF Juruena, M Bocharova, B Agustini, AH Young
Journal of affective disorders 233, 45-67, 2018
972018
Effectiveness of psychoeducation for depression: a systematic review
MFS Tursi, CW Baes, FRB Camacho, SMC Tofoli, MF Juruena
Australian & New Zealand Journal of Psychiatry 47 (11), 1019-1031, 2013
862013
Overlap between atypical depression, seasonal affective disorder and chronic fatigue syndrome
MF Juruena, AJ Cleare
Brazilian Journal of Psychiatry 29, s19-s26, 2007
85*2007
Treatment of psychosis: 30 years of progress
IR De Oliveira, MF Juruena
Journal of Clinical Pharmacy and Therapeutics 31 (6), 523-534, 2006
842006
Depression and stress: is there an endophenotype?
AF Mello, MF Juruena, CM Pariante, AR Tyrka, LH Price, LL Carpenter, ...
Brazilian Journal of Psychiatry 29, s13-s18, 2007
83*2007
Clomipramine in vitro reduces glucocorticoid receptor function in healthy subjects but not in patients with major depression
LA Carvalho, MF Juruena, AS Papadopoulos, L Poon, R Kerwin, ...
Neuropsychopharmacology 33 (13), 3182-3189, 2008
782008
Emotional abuse in childhood is a differential factor for the development of depression in adults
CMS Martins, CVW Baes, SM de Carvalho Tofoli, MF Juruena
The Journal of nervous and mental disease 202 (11), 774-782, 2014
682014
Bipolar I and II disorder residual symptoms: oxcarbazepine and carbamazepine as add-on treatment to lithium in a double-blind, randomized trial
MF Juruena, GL Ottoni, R Machado-Vieira, RM Carneiro, N Weingarthner, ...
Progress in Neuro-Psychopharmacology and Biological Psychiatry 33 (1), 94-99, 2009
682009
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20